Revvity Inc SEC Filings

Revvity, Inc. (RVTY): Schedule 13G/A — Janus Henderson Group plc reported beneficial ownership of 7,627,259 American Depositary Shares, representing 6.6% of the class. The filer reported 0 sole voting and dispositive power and 7,627,259 shared voting and dispositive power. The filing is certified as being made in the ordinary course and not for the purpose of changing or influencing control.

Separately, the filing notes that Janus Henderson Investors US LLC (JHIUS) may be deemed to beneficially own 7,588,607 shares, or 6.5%, with shared voting and dispositive power and no sole powers. The report identifies the reporting person’s type as IA, HC and includes a standing power of attorney for signature authority.

Revvity, Inc. received a Schedule 13G/A (Amendment No. 1) from EdgePoint Investment Group Inc. disclosing a passive stake. EdgePoint reports beneficial ownership of 8,574,280 shares of common stock, representing 7.39% of the class as of the event date.

EdgePoint has sole voting and dispositive power over 5,628,116 shares and shared voting and dispositive power over 2,946,164 shares. The certification states the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control.

Revvity, Inc. (RVTY) reported Q3 results with total revenue of $698.9 million, up 2% year over year. Diluted EPS was $0.40 as net income declined to $46.7 million amid higher interest and other expenses. Gross margin fell 266 bps to 53.6% and operating margin also compressed, driven by increased tariffs, unfavorable foreign exchange, and product mix.

By segment, Diagnostics rose 3% to $356.1 million, led by Reproductive Health, while Life Sciences inched up 1% to $342.8 million on stronger Software. Year‑to‑date cash from operations was $407.0 million. The company repurchased 6.75 million shares for $647.9 million year to date, ending the quarter with 114.0 million shares outstanding, and the Board authorized a new $1.0 billion repurchase program on October 23, 2025. The quarterly dividend remained $0.07 per share.

Revvity, Inc. (RVTY) President, Chief Executive Officer and Director Prahlad R. Singh reported a bona fide gift of 9,420 shares of common stock on 10/29/2025.

The shares were transferred to an irrevocable trust for the sole benefit of his children, with his spouse serving as trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest.

Following the transaction as of October 29, 2025, Singh beneficially owned 96,838 shares direct and 46,583 shares indirect through the Singh Family Trust of 2021.

Revvity (RVTY) appointed Anita Gonzales as Vice President and Chief Accounting Officer, effective October 23, 2025. Gonzales has served as the company’s Vice President and Controller since May 2023, after joining in March 2021 to lead integration and controllership initiatives. She previously spent a decade at General Electric in corporate audit and GE Aviation leadership roles, and earlier advanced to Senior Manager at PwC. Gonzales holds MPA and BBA degrees from the University of Texas at Austin and is a CPA.

Maxwell Krakowiak, Senior Vice President and Chief Financial Officer of Revvity, Inc. (RVTY), reported a transaction dated 09/15/2025 in which he surrendered 559 shares of Revvity common stock at an effective price of $82.87 per share. The filing shows 12,217 shares beneficially owned following the transaction, held directly. The Form 4 explains these shares were surrendered to satisfy a tax withholding obligation upon vesting of restricted stock units originally granted on 09/15/2022. The form was signed by a power of attorney on behalf of the reporting person on 09/17/2025.

Anita Gonzales, Vice President and Controller of Revvity, Inc. (RVTY), reported the surrender of 149 shares of common stock on 09/15/2025 at a price of $82.87 per share to satisfy tax withholding obligations arising from restricted stock units originally granted on 09/15/2022. After this transaction, the reporting person beneficially owned 4,340 shares, held directly. The Form 4 filing was submitted by power of attorney on 09/17/2025.

This disclosure reflects a routine, non-cash settlement of vested equity for tax purposes rather than an open-market sale or purchase. The filing identifies the transaction code and ties the share reduction explicitly to the RSU agreement, indicating compliance with Section 16 reporting requirements.

Alexis P. Michas, a director of Revvity, Inc. (RVTY), reported a sale of common stock on 08/27/2025. The filing shows 500 shares were disposed of at a price of $89.01. The report records 7,270 shares as beneficially owned indirectly through The Cayre and Alexis Michas Foundation Corp., and the filing includes an explanation that certain reported shares relate to dividends in the Reporting Person's Deferred Compensation Plan account. The filing is signed by a power of attorney on behalf of the reporting person and includes the foundation disclosure that the Reporting Person disclaims beneficial ownership of foundation-held shares except to the extent of any pecuniary interest.